SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sugen (SUGN)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
550 25 0 SUGN
Emcee:  Phillipa Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
75 bob, i really don't follow $tk very closely (esp. biotech). any mid-staged james-11/7/1997
74 James With the weakness on the news of the new offering it seems like another bob s-11/7/1997
73 <CURE FOR CANCER is worth at least $1 trillion> Your enthusiam in sugn ijames-10/31/1997
72 I would estimate that the CURE FOR CANCER is worth at least $1 trillion. $UGN franco-10/31/1997
71 Can't agree more with you! sugn follows a conventional path, which has beejames-10/30/1997
70 I think $UGN is the mother of all baby biotechs because it is KING of the TK Infranco-10/30/1997
69 <He formerly served as a director of Genentech Development Corporation, Amgejames-10/30/1997
68 Stephen Evans-Freke, Founder, Chairman and Chief Executive Officer of Sugen hasKevin Ponzo-10/30/1997
67 < 1. Zeneca, which is a corporate collaborator with Sugen, will purchase james-10/30/1997
66 The prospectus for Sugen's 2.5 million share offering is now available onliKevin Ponzo-10/30/1997
65 how do you know that it sits on a gold mine? by the way gold doesn't worthjames-10/29/1997
64 $UGN boomin' over $19- looks like the financing deal caused the dip, and nofranco-10/29/1997
63 I think the SUGN pullback was an event directly related to the financing that wfranco-10/28/1997
62 They announced a private placement on Friday after market close. Where do you tJonathan Rothschild-10/26/1997
61 SU101/BCNU You got it absolutely right. Sugen's future is not dependent onjames-10/25/1997
60 Perhaps the important component of Lehman Bros report on new FDA regulations isPeter J.-10/10/1997
59 The bottom line in the Lehman report is the short term price target of $29. Thefranco-10/10/1997
58 ... can't seem to put the Adobe Acrobat file ("report on FDA") inPeter J.-10/9/1997
57 The Research is in Adobe Acrobat format (which probably explains why you couldnPeter J.-10/9/1997
56 Peter, can you please post research from LehmanNikole Wollerstein-10/9/1997
55 check out biz.yahoo.com and check out lehman.com and hold on to your hatsPeter J.-10/9/1997
54 Re: additive efficacy - the problem I can see here is that Chemotherapy killsNikole Wollerstein-10/9/1997
53 Sugen Inc To Expand SU101 Clinical Trials Dow Jones NewswiJ-10/8/1997
52 YES! And check out the news ticker tomorrow AM for the BIG NEWS! I've had franco-10/8/1997
51 Highest close. UBS Securities confernce is in progress.Nikole Wollerstein-10/7/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News